Pharmaceutical News

RSS

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.

30 Sep 2019

FDA warns about Ranitidine containing known carcinogen NDMA

The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.

26 Sep 2019

High-risk heart patients may not require long-term aspirin use after stent placement

High-risk patients undergoing coronary stent procedures may not require long-term aspirin use after stent placement, Mount Sinai researchers report in a groundbreaking study

26 Sep 2019

Arthritis drug could be used to treat lichen planus skin rash

Constant itchy, painful bumps, scaly arms and legs, and damaged nails make lichen planus an inflammatory skin disease that's both frustrating and painful for patients trying to keep their quality of life.

26 Sep 2019

Study finds nearly one in three patients with lupus uses prescription opioids for pain

Although there is little evidence that opioids effectively reduce pain from rheumatic diseases, a new study finds nearly one in three patients with lupus uses prescription opioids, often lasting longer than a year.

26 Sep 2019

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Like catching two fish with one worm, treating two problems with a single drug is efficient, but exceedingly difficult.

25 Sep 2019

Study shows metformin is safe for patients with mild-to- moderate kidney disease

Over the years, there has been uncertainty over which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

25 Sep 2019

Cheaper drug equally effective in preserving cardiovascular function in boys with DMD

A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne muscular dystrophy (DMD).

24 Sep 2019

As off-label use spreads, supplies of niche drugs and patients’ patience grow short

Medical treatment has knocked down tumors in 6-year-old Easton Daniels' brain, but the drug used also wiped out his immune system.

24 Sep 2019

New drug delivery system could be a boon for those on a multi-drug regimen

Researchers from the University of North Carolina at Chapel Hill have developed a unique new multi-drug delivery system that could p-rove to be useful for persons who need to take several drugs in a day as part of a regimen.

23 Sep 2019

Data on health-related quality of life often not collected for investigational cancer drugs

A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they are submitted for reimbursement, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

23 Sep 2019

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.

21 Sep 2019

Advancements in pain management are giving new options to patients

Hardly a day goes by without the public being warned about the dangers of opioids. But still, according to the National Institute on Drug Abuse, more than 130 people die every day of opioid overdose and the problem is getting worse.

21 Sep 2019

Pembrolizumab provides added benefit for subpopulations of patients with metastatic NSCLC

In early July, the German Institute for Quality and Efficiency in Health Care conducted two early benefit assessments to investigate whether certain drug combinations with pembrolizumab have advantages in comparison with the respective appropriate comparator therapy for patients with metastatic squamous or non-squamous non-small cell lung cancer.

20 Sep 2019

Hill hodgepodge: Pelosi draws from Democrats, GOP and Trump for drug plan

House Democratic leaders on Thursday unveiled an aggressive plan to lower drug prices through negotiations between federal health officials and the makers of some of the most expensive drugs.

20 Sep 2019

Knowing when and how to taper off opioid dosage crucial to safe pain management

Many healthcare providers today try to avoid administering or prescribing opioid pain medications when possible because of the narcotics' addictive properties. But for some patients, opioid medications remain the most effective, most appropriate treatment for their subjective pain complaints.

20 Sep 2019

Diabetes drug can also be used to treat heart failure

Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.

19 Sep 2019

Review highlights medication underuse in the treatment of opioid use disorder

Though research shows that medication-assisted treatment can help people who are addicted to opioids, the three drugs approved by the Food and Drug Administration (FDA) are underused, according to a review of current medical data on opioid addiction in the U.S.

19 Sep 2019

All-in-one pill reduces estimated risk of cardiovascular disease, study shows

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25% in a study published today in the New England Journal of Medicine.

19 Sep 2019

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

Pharmaceutical News

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

FDA warns about Ranitidine containing known carcinogen NDMA

High-risk heart patients may not require long-term aspirin use after stent placement

Arthritis drug could be used to treat lichen planus skin rash

Study finds nearly one in three patients with lupus uses prescription opioids for pain

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Study shows metformin is safe for patients with mild-to- moderate kidney disease

Cheaper drug equally effective in preserving cardiovascular function in boys with DMD

As off-label use spreads, supplies of niche drugs and patients’ patience grow short

New drug delivery system could be a boon for those on a multi-drug regimen

Data on health-related quality of life often not collected for investigational cancer drugs

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Advancements in pain management are giving new options to patients

Pembrolizumab provides added benefit for subpopulations of patients with metastatic NSCLC

Hill hodgepodge: Pelosi draws from Democrats, GOP and Trump for drug plan

Knowing when and how to taper off opioid dosage crucial to safe pain management

Diabetes drug can also be used to treat heart failure

Review highlights medication underuse in the treatment of opioid use disorder

All-in-one pill reduces estimated risk of cardiovascular disease, study shows

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News